SB-209670
SB-209670 is an extremely potent and highly specific non-peptide, subnanomolar endothelin (ET) receptor antagonist. SB 209670 selectively inhibits binding of 125I-labeled ET-1 to cloned human ET receptor subtypes ETA and ETB (Ki=0.2 and 18 nM, respectively) . SB 209670 produces a dose-dependent reduction in blood pressure in hypertensive rats, protects from ischemia-induced neuronal degeneration in a gerbil stroke model, and attenuates neointima formation following rat carotid artery balloon angioplasty[1].
Product Specifications
CAS Number
157659-79-5
UNSPSC
12352005
Target
Endothelin Receptor
Type
Reference compound
Related Pathways
GPCR/G Protein
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Assay Protocol
https://www.medchemexpress.com/sb-209670.html
Solubility
10 mM in DMSO
Smiles
O=C([C@@H]1[C@@H](C2=CC=C(OCO3)C3=C2)C4=C(C=C(OCCC)C=C4)[C@H]1C5=CC=C(OC)C=C5OCC(O)=O)O
Molecular Formula
C29H28O9
Molecular Weight
520.53
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
Phase 2
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
![3,5-Dimethyl-4-[3- (3-methyl-5-isoxazolyl) propoxy]-benzonitrile](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
3,5-Dimethyl-4-[3- (3-methyl-5-isoxazolyl) propoxy]-benzonitrile
MOX1 (MEOX1) Mouse Monoclonal Antibody [Clone ID: LBI2F4]
